Ghostine has served as CEO of Geneva-based Firmenich, the world's largest privately owned perfume and taste company, since 2014.
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
He was appointed a Board member and the Chairman in 2012.
Peacock also serves as a Director and Chair of the Audit and Finance Committee of UCB SA, a biopharmaceutical company focusing on neurology and immunology
Waksal holds a successful track record of founding, scaling and advising growth-oriented companies.
Gupta to retire at the end of his current term on May 12, 2022, after more than a decade of service, during which time Avantor has transformed into a global life sciences leader
Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021
It plays a pivotal role in monitoring pharmaceutical pricing
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
Subscribe To Our Newsletter & Stay Updated
